MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Serum cholesterol levels over time and risk of Parkinson’s disease

V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz (Tel A viv, Israel)

Meeting: 2017 International Congress

Abstract Number: 18

Keywords: Lipid metabolism, Neuroprotective agents

Session Information

Date: Monday, June 5, 2017

Session Title: Epidemiology

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To evaluate the association of serum cholesterol levels over time with the risk of Parkinson’s disease (PD); among statin-free individuals.

Background: High levels of serum cholesterol are well-established risk factors in developing coronary artery disease and stroke. Whether cholesterol levels play a similar role in PD remains elusive.

Methods:  A Population-based large-scale cohort study; based on medical data of Maccabi Healthcare Services, a large Israeli healthcare organization that serves 25% of the population. The cohort included statin-free individuals with repeated cholesterol profile measures during a 13-year period (1999-2012).  Mean annual levels for serum total, low and high density lipoprotein cholesterol (TC, LDL-C, and HDL-C, respectively) were included in a chronological order for each individual. PD incidence was assessed using a validated anti-Parkinsonian drugs (APD) tracing approach, considering APD purchase profiles, first purchase age, purchase  density and length of follow up period. Cox proportional hazard models with time dependent covariates were applied to estimate PD risk (HR) associated with cholesterol levels over time. Analysis was stratified by sex and age-groups at 1st blood test.

Results: The cohort included 261,638 individuals (aged 40-79 at the first blood test, 42.7% men) with 2,093,104 repeated measures. During a mean follow up of 7.9 (±3.6) years, 764 (0.3% among 40-64 years; 3.3% among 65+ years) incident PD cases were detected. Among men, middle and upper tertiles of TC mg/dl (middle: 180-209; upper ≥ 210) and LDL-C (middle: 110-139; upper ≥140), as compared to the lowest tertiles, were significantly associated with a lower PD risk, in most age groups. Age pooled HRs (95%CIs) were 0.91 (0.83-1.04) and 0.86 (0.77-0.96) for TC and 0.90 (0.82-0.99) and 0.86 (0.76-0.97) for LDL-C, respectively. Among women, insignificant associations were found between TC or LDL-C levels and PD risk. For HDL-C, null results were found for PD risk among both sexes. 

Conclusions: Higher serum TC and LDL-C levels among men over time indicated a decreased PD risk. The potential role of serum cholesterol affecting PD etiology or as a marker of incipient PD warrants further investigation.

To cite this abstract in AMA style:

V. Rozani, T. Gurevich, N. Giladi, B. El-Ad, J. Tsamir, B. Hemo, C. Peretz. Serum cholesterol levels over time and risk of Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/serum-cholesterol-levels-over-time-and-risk-of-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/serum-cholesterol-levels-over-time-and-risk-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley